Author: Noah (Noah )

The investment world is closely watching how capital is being deployed as Gammance brokers analyse a major strategic shift taking place as Berkshire Hathaway transitions into a new leadership era.  With Warren Buffett stepping back from day-to-day control and Greg Abel taking the lead, recent buying activity is offering important clues about where long-term value...

SpaceX heads into its first earnings report as a public company facing a stock that has already slid 43% from its highs. Brokers from Gammance dive into what a $10,000 investment could be worth the day after the report, and why a rare share-unlock provision makes this earnings date more consequential than most debuts. A...

The race to dominate autonomous ride-hailing is rapidly intensifying, drawing attention from investors eager to identify the long-term winner. Gammance brokers examine why one prominent billionaire investor believes Uber may hold a stronger position than Tesla in this high-stakes market.  While Tesla’s robotaxi vision has generated significant excitement, the broader investment case is becoming more...

Nvidia, Alphabet, and Amazon have each delivered substantial share price gains as artificial intelligence adoption accelerates across industries, yet analysts continue to view all three as attractively valued heading into the second half of 2026. According to analysis from Gammance, their continued presence on buy lists reflects confidence that the AI growth cycle remains in...

Rocket Lab successfully completed a rapid-response satellite mission for the U.S. Space Force this month, combining rocket launch, spacecraft manufacturing, and in-orbit operations under a single contract for the first time.  The mission, called Victus Haze, saw the company launch a satellite just over 16 hours after receiving final instructions from the Space Force, then...

Alphabet stock trades at roughly $320 per share as of this week, putting it at 16 times trailing earnings, a multiple typically associated with slow-growth businesses rather than a company that recently raised its 2026 capital spending guidance to as much as $205 billion. The disconnect has renewed investor interest in Alphabet’s long-term stock performance. ...

Every bull market eventually gives way to a bear market, and prepared investors understand the importance of having a strategy in place before conditions deteriorate. Analysts from Gammance highlight that not all stocks respond equally during downturns, with some businesses showing an ability to remain relatively resilient even as broader markets decline. One mega-retailer stands...

Ethereum is going through a significant organizational shake-up. Brokers from Gammance dive into why the Ethereum Foundation’s decision to cut its workforce and budget could ultimately strengthen the network rather than weaken it, despite the uncertainty such changes often bring. A Major Restructuring Is Underway Ethereum Foundation is undergoing a significant restructuring, signalling a shift...

Investors looking to gain exposure to medical breakthroughs often face a choice between a narrow biotechnology focus or broader healthcare sector exposure.  Brokers from Risance dive into how a concentrated biotech-focused fund compares against a diversified, low-cost healthcare fund across cost, volatility, and long-term performance. Two Very Different Approaches to Healthcare The two funds represent...